BIO Double Helix Sponsor
Sponsors

Company Profile

Ventaira Pharmaceuticals

Drug Delivery

1801 Watermark Drive
Suite 100
Columbus, OH 43215
USA
www.ventaira.com 		Incorporated in 2000
20 Employees 		Privately Held

This Year's Highlights

  • Identified THC as the most viable drugs to be used with Ventaira's inhaler.
  • Announced completion of a pharmacokinetics and scintigraphy study with fluticasone propionate. Data was positive and showed that Ventaira's inhaler and EDH technology can deliver drug deep into the lung.

Anticipated Highlights

  • Initiate human clinical trial with THC in Switzerland using Ventaira's inhaler and announce creation of scienfitic advisory board.
  • Complete Series D financing
  • Announce Phase 1 results from THC trial

Corporate Mission

Ventaira is an emerging inhalation device company leveraging science and technology to develop novel inhalation treatments that improve current patient therapies and quality of life.